Callion Corporation is a specialty pharmaceutical and medical device company focused on introducing a new patented drug technology, first of it's kind, related to colon cancer screening.
Business Model: Revenues will come from Gastroenterologists and primary care physicians referring patients and hospitals stocking the product in house. Sales transaction will go through our website using online pharmacy service with a retail price of $40.